Stroma cell labeling indices of CD4**, CD8*, Foxp3*, CD68*, CD163**, and CD11c* were significantly higher in both the tumor core and the invasive front of cSCC samples as compared to BCC (*p < 0.001; **p < 0.050). This evidence concerns the gene ITGAX and skin basal cell carcinoma.